Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score

Nucleos(t)ide analogs (NA) suppress hepatitis B virus (HBV) replication and reduce the risk of hepatocellular carcinoma (HCC). However, NA cannot suppress carcinogenesis completely in patients with chronic hepatitis B. The aims of this study were to identify risk factors for HCC and develop a refine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Shun, Kurosaki, Masayuki, Joko, Kouji, Marusawa, Hiroyuki, Kondo, Masahiko, Kojima, Yuji, Uchida, Yasushi, Kimura, Hiroyuki, Tsuji, Keiji, Yagisawa, Hitoshi, Kusakabe, Atsunori, Kobashi, Haruhiko, Akahane, Takehiro, Tamaki, Nobuharu, Kirino, Sakura, Abe, Takehiko, Yoshida, Hideo, Matsushita, Tomomichi, Hasebe, Chitomi, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400741/
https://www.ncbi.nlm.nih.gov/pubmed/32747646
http://dx.doi.org/10.1038/s41598-020-69522-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400741/
https://www.ncbi.nlm.nih.gov/pubmed/32747646
http://dx.doi.org/10.1038/s41598-020-69522-w

Ejemplares similares